0000899243-19-023129.txt : 20190909
0000899243-19-023129.hdr.sgml : 20190909
20190909163808
ACCESSION NUMBER: 0000899243-19-023129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190905
FILED AS OF DATE: 20190909
DATE AS OF CHANGE: 20190909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reed Joshua
CENTRAL INDEX KEY: 0001746541
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36332
FILM NUMBER: 191083434
MAIL ADDRESS:
STREET 1: C/O ALDEYRA THERAPEUTICS, INC.
STREET 2: 131 HARTWELL AVENUE, SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aldeyra Therapeutics, Inc.
CENTRAL INDEX KEY: 0001341235
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 HARTWELL AVENUE
STREET 2: SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-761-4904
MAIL ADDRESS:
STREET 1: 131 HARTWELL AVENUE
STREET 2: SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: Aldexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20130102
FORMER COMPANY:
FORMER CONFORMED NAME: Neuron Systems Inc
DATE OF NAME CHANGE: 20051012
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-05
0
0001341235
Aldeyra Therapeutics, Inc.
ALDX
0001746541
Reed Joshua
C/O ALDEYRA THERAPEUTICS, INC.
131 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Common Stock
2019-09-05
4
P
0
3200
4.71
A
35774
D
Includes 2,937 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2019.
/s/ Joshua Reed
2019-09-09